Year: 1998
Type: article
Abstract: BACKGROUND.Automated cytology devices have utility in quality assurance applications, but the effectiveness of these devices in primary screening is unknown. METHODS.Enrollment smears obtained from 7323 women participating in a population-based study sponsored by the National Cancer Institute were screened manually in Costa Rica and then evaluated independently in the U.S. with the PAPNET system (Neuromedical Systems, Inc., Suffern, NY), a semiautomated, neural network-based device.Smears with abnormal PAPNET images were microscopically rescreened and then diagnosed by a U.S. cytopathologist.ThinPrep slides (Cytyc Corporation, Boxborough, MA), prepared from rinses of the cytologic sampler, and cervigrams (National Testing Laboratories, Fenton, MO) were also evaluated.Women with any abnormal cytologic diagnosis or a positive cervigram were referred for colposcopy with biopsy and definitive therapy if indicated.
Source: Cancer
Institutions: Johns Hopkins University, Johns Hopkins Medicine, National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Institutes of Health, Centre international de recherche sur le cancer, Ministerio de Salud, Costa Rican Department of Social Security, Women & Infants Hospital of Rhode Island, Philadelphia Foundation, NOAA Office of National Marine Sanctuaries
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4230815152